Shuzo Hamamoto
Overview
Explore the profile of Shuzo Hamamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
1294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naiki T, Naiki-Ito A, Murakami A, Kato H, Sugiyama Y, Kawai T, et al.
Prostate Cancer
. 2025 Mar;
2025:8165686.
PMID: 40046611
A need exists for effective treatments for prostate cancer (PCA) due its re-emergence following androgen deprivation therapy, a major clinical problem. In a previous study, we presented evidence on the...
2.
Yanase T, Naiki T, Naiki-Ito A, Okawa R, Niwa S, Shimizu N, et al.
IJU Case Rep
. 2025 Mar;
8(2):174-178.
PMID: 40034913
Introduction: Standard treatments for squamous cell carcinoma of the anal canal include chemoradiotherapy and surgical resection. We report a rare case of squamous cell carcinoma of the anal canal with...
3.
Yamashita S, Hamamoto S, Furukawa J, Fujita K, Takahashi M, Miyake M, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941841
Background/objectives: The efficacy and safety of nivolumab plus ipilimumab (NIVO + IPI) for elderly patients with metastatic renal cell carcinoma have not been reported with sufficient evidence. Our study therefore...
4.
Miyazawa K, Yamaguchi S, Iguchi T, Chikazawa I, Yasui T, Takahashi S, et al.
Int J Urol
. 2025 Feb;
PMID: 39930597
This third edition of the Japanese Clinical Practice Guidelines for Urinary stones (2023) has been developed under the leadership of the Japanese Urological Association, the Japanese Society of Endourology and...
5.
Tasaki Y, Hamamoto S, Yamashita S, Furukawa J, Fujita K, Tomida R, et al.
Front Immunol
. 2025 Jan;
15():1483956.
PMID: 39850887
Introduction: Immune-related adverse events (irAEs) induced by immune checkpoint inhibitors are difficult to predict and can lead to severe events. Although it is important to develop strategies for the early...
6.
Kawase K, Hamamoto S, Unno R, Taguchi K, Okada A, Yasui T
Urolithiasis
. 2024 Dec;
53(1):16.
PMID: 39724472
The early stages of kidney crystal formation involve inflammation and hypoxia-induced cell injury; however, the role of the hypoxic response in kidney crystal formation remains unclear. This study investigated the...
7.
Morikawa T, Hamamoto S, Gonda M, Taguchi K, Unno R, Torii K, et al.
Sci Rep
. 2024 Nov;
14(1):27365.
PMID: 39521906
This study evaluated the direct and indirect thermal effects of various surgical energy devices using an ex-vivo model. Two types of three devices were evaluated: ENSEAL™ X1 Curved Jaw Tissue...
8.
Hamamoto S, Tasaki Y, Yamashita S, Furukawa J, Fujita K, Tomida R, et al.
Front Oncol
. 2024 Sep;
14:1400041.
PMID: 39286026
Introduction: Pretreatment hemoglobin and neutrophil levels were previously reported to be important indicators for predicting the effectiveness of ipilimumab plus nivolumab (IPI + NIVO) therapy for renal cell carcinoma (RCC)....
9.
Hinata N, Murakami S, Nakano Y, Hara I, Kondo T, Hamamoto S, et al.
Int J Clin Oncol
. 2024 Aug;
29(10):1548-1556.
PMID: 39110358
Background: This study aimed to compare the efficacy of robot-assisted partial nephrectomy for completely endophytic renal tumors with the reported outcomes of conventional laparoscopic partial nephrectomy and investigate the transition...
10.
Torii K, Hamamoto S, Taguchi K, Okada S, Inoue T, Isogai M, et al.
Sci Rep
. 2024 Jul;
14(1):17134.
PMID: 39054390
Management of large pediatric kidney calculi (PKC) is challenging. This study aimed to evaluate the efficacy and safety of miniature endoscopic combined intrarenal surgery (mini-ECIRS) for PKC. We retrospectively analyzed...